Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a recent study.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1OX07Fz
No comments:
Post a Comment